MarginsXMarginsX
Home › Markets › Industrials › LAB

Standard BioTools Inc. (LAB)

LAB trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6210
-12.21% on the day
Market cap
$245.2M
Micro cap
Revenue · 2025
$85.3M
-6.2% on 2024
Net income · 2025
-$74.9M
-87.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1162194/000119312526108326/0001193125-26-108326-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerLAB on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2011
SEC CIK0001162194
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$85.3M
Net income-$74.9M
Operating income-$110.2M
Net margin-87.8%
Operating margin-129.2%
Revenue growth-6.2%
Cash$120.9M
Total assets$567.8M
P/E (computed)Net income was not positive
P/S (computed)2.9×

Warning signs

Cash runway
50.0 months
$267.5M cash at September 30, 2026
Share count, 1 year
+2.7%
2025-11-02 to 2026-11-01 · +397.2% over 3 years
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
$14.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$267.5M cash; operating cash flow -$16.1M a quarter.Report 2026-09-30
Shares outstanding394,790,441 (2026-11-01); 384,565,414 a year earlier; 79,395,035 three years earlier.Cover page 2026-11-01
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-07-24
AuditorPricewaterhouseCoopers LLP, Irvine, California, United StatesPCAOB Form AP 2026-03-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $14.4M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$19.4M$13.5M-$6.2M$267.5M$300K$84.4M10-Q 2026-11-03
Q2 2026
2026-06-30
$20.1M-$26.8M-$10.3M$270.0M$299K$84.6M10-Q 2026-08-05
Q1 2026
2026-03-31
$21.1M$127.1M-$46.6M$265.8M$299K$86.3M10-Q 2026-05-06
Q4 2025
2025-12-31
$23.8M$19.3M-$1.2M$120.9M$299K$85.3M10-K 2026-03-16
Q3 2025
2025-09-30
$19.6M-$34.7M-$22.2M$129.4M$299K$86.3M10-Q 2026-11-03
Q2 2025
2025-06-30
$21.8M-$33.5M-$20.7M$158.6M$299K$88.8M10-Q 2026-08-05
Q1 2025
2025-03-31
$20.2M-$26.0M-$30.3M$150.9M$299K$89.6M10-Q 2026-05-06
Q4 2024
2024-12-31
$24.8M-$34.1M-$14.1M$166.7M$299K$114.9M10-K 2026-03-16

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-10-30
Latest annual report10-K2026-03-16
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-16
Latest proxyDEFA14A2026-04-27

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+10.9%
1 month+7.6%
3 months-5.3%
Year to date-44.5%
1 year-40.8%
From 52-week high-57.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
NAUTNautilus Biotechnology Inc.$2.10-9.48%$267.5M
QTRXQuanterix Corporation$2.84-3.07%$134.8M
PACBPacific Biosciences of California Inc.$1.84-6.12%$575.8M
SEERSeer Inc.$1.48-5.73%$82.6M
CTKBCytek Biosciences Inc.$5.63-3.60%$736.3M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
PRPOPrecipio Inc.$19.96-9.81%$35.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier